SCHEMBL27328352

SCHEMBL27328352

O=c1c(Br)c(-c2ccccc2)[nH]c2ncnn12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.41
TP53 P04637 1/20 0.38
MDM2 Q00987 1/20 0.37
KDM4E B2RXH2 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
PLA2G10 O15496 1/20 0.37
GAA P10253 1/20 0.37
HSD17B10 Q99714 1/20 0.37
EGLN2 Q96KS0 1/20 0.36
LMNA P02545 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PKM P14618 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
MAPT P10636 3/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
XDH P47989 1/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20074091 0.75 KDM5B (0.39) TSHR
SCHEMBL20074288 0.70 KDM4E (0.50) TDP1TP53KDM4EALDH1A1HPGD
SCHEMBL31676989 0.68 KDM5B (0.52) TDP1TSHR
SCHEMBL21721728 0.67 KDM5B (0.53) TP53KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL20074331 0.67 KDM5B (0.43) TDP1ALDH1A1TSHRGCGRMAPK14
SCHEMBL31676967 0.66 KDM5B (0.47) ALDH1A1SMN1; SMN2TSHR
SCHEMBL20074113 0.66 KDM5B (0.44) TDP1ALDH1A1TSHRADORA2A
SCHEMBL20074103 0.66 KDM5B (0.42) KDM4EALDH1A1HSD17B10EGLN2LMNA
SCHEMBL21721676 0.66 KDM5B (0.50) TDP1ALDH1A1HPGDGAAHSD17B10
SCHEMBL31676999 0.65 KDM5B (0.49) HPGDHSD17B10EGLN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12016863-B2 Inhibitors of RSV replication and applications thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2024-06-25 US disclosed
US-12016863-B2 Inhibitors of RSV replication and applications thereof GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2024-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12016863-B2 Inhibitors of RSV replication and applications thereof SNRPE, PRDX1, PRDX6 TDP1 2965/4885TP53 4240/4885MDM2 2984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.